CN105541687B - A kind of method of the separated in synchronization from orange peel and purifying β kryptoxanthin and stigmasterol - Google Patents

A kind of method of the separated in synchronization from orange peel and purifying β kryptoxanthin and stigmasterol Download PDF

Info

Publication number
CN105541687B
CN105541687B CN201510941144.1A CN201510941144A CN105541687B CN 105541687 B CN105541687 B CN 105541687B CN 201510941144 A CN201510941144 A CN 201510941144A CN 105541687 B CN105541687 B CN 105541687B
Authority
CN
China
Prior art keywords
kryptoxanthin
stigmasterol
orange peel
crystal
synchronization
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201510941144.1A
Other languages
Chinese (zh)
Other versions
CN105541687A (en
Inventor
孙志高
黄巧娟
马亚琴
黄林华
郭莉
黄学根
谭祥
王珺
王�华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Southwest University
Original Assignee
Southwest University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Southwest University filed Critical Southwest University
Priority to CN201510941144.1A priority Critical patent/CN105541687B/en
Publication of CN105541687A publication Critical patent/CN105541687A/en
Application granted granted Critical
Publication of CN105541687B publication Critical patent/CN105541687B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/24Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by six-membered non-aromatic rings, e.g. beta-carotene
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Abstract

The present invention disclose a kind of method that the separated in synchronization from orange peel purifies β kryptoxanthin and stigmasterol, step one, orange peel is dried and is milled;Step 2, pretreated raw material is extracted with absolute ethyl alcohol, be concentrated under reduced pressure to give total ester extract;Step 3, total ester extract is dissolved in extract solution is obtained in n-hexane, then to adding the KOH ethanol solutions to carry out saponification in extract solution, then extracted, finally washed and be concentrated under reduced pressure;Step 4, isolated and purified using chromatography, collect the eluent consistent with standard items;Step 5, Double solvent method crystallization is carried out to the concentrate of the eluent from n-hexane acetone first, crystallize out stigmasterol crystal, then crystallized from ether methyl alcohol, crystallize out β kryptoxanthin crystal.Using a kind of separated in synchronization from orange peel purifying β kryptoxanthin of the invention and the method for stigmasterol, β kryptoxanthin and stigmasterol can be extracted from orange peel simultaneously, method simple practical, good separating effect, the wherein purity of β kryptoxanthin are up to 98.48%.

Description

A kind of method of the separated in synchronization from orange peel and purifying β-kryptoxanthin and stigmasterol
Technical field
The present invention relates to the separated in synchronization from orange peel and the technical matters and parameter of purifying β-kryptoxanthin and stigmasterol.
Background technology
β-kryptoxanthin is one kind of carotenoid Lutein, various with anticancer, anti-oxidant, suppression osteoporosis etc. Physiological function, structural formula is as follows:
It is primarily present in higher plant, fungi, blue-green algae etc.;Recent studies suggest that, β-kryptoxanthin or one kind are good Vitamin A precursor material.
Phytosterol is a kind of natural active matter being present in plant, be plant constitute cell membrane into point it One, be also various hormones, vitamin D and steroidal compounds synthesis precursor, with anticancer, anti-inflammatory, anti-oxidant, reduction blood fat and The physiological functions such as cholesterol, reduction coronary heart disease generation.Stigmasterol is one of Typical Representative of phytosterol, and structural formula is as follows:
It is primarily present in all kinds of plants and grease deodorized distillate.Stigmasterol is special except the general pharmacology with phytosterol Outside property, also it is mainly used in synthesizing various hormones and vitamin D3, it is widely used in biological and pharmaceuticals industry.Because orange peel comes Source is easy and cost is relatively low, and natural β-kryptoxanthin is extracted from orange peel turns into the main path for obtaining β-kryptoxanthin;Orange peel In in addition to containing pectin, cellulose, pigment, also containing bioactivators such as flavones, sterols, but at present on being carried from skin slag The research for taking stigmasterol is rarely reported.
Described content in documents below, can be as β-kryptoxanthin and the judging basis of stigmasterol:1st, friend Liu Yu is red The extraction separation of potato cauline leaf chemical composition and Structural Identification [D] Jilin University, 2013;2nd, in Liu Zhihua, Yang Zhixue common callas The separation of constituent phytosterols and Structural Identification [J] Chinese pharmacists, 2007,10 phases:978-979.DOI:doi:10.3969/ j.issn.1008-049X.2007.10.015;3rd, well phoenix, Wang Li, Xu Shuanshuan wait the separation of beta-cryptoxanthin in capsicums to prepare [J] Food Sciences, the 2013, the 6th phase:10-13;4、Khachik,F,Chang,ANGana,A,Mazzola,E.Partial synthesis of(3R,6'R)-alpha-cryptoxanthin and(3R)-beta-cryptoxanthin from(3R, 3'R,6'R)-lutein[J].Journal of Natural Products,2007,70(2):220-226.
The content of the invention
A kind of method that the present invention provides separated in synchronization from orange peel and purifying β-kryptoxanthin and stigmasterol, can obtain simultaneously Obtain the β-kryptoxanthin and stigmasterol of high-purity.
Technical scheme is as follows:
A kind of method of separated in synchronization from orange peel and purifying β-kryptoxanthin and stigmasterol, it is critical only that including following Step:
Step one, orange peel is dried and is milled;
Step 2, pretreated raw material is extracted with absolute ethyl alcohol, be concentrated under reduced pressure to give total ester extract;
Step 3, total ester extract is dissolved in extract solution is obtained in n-hexane first, then to extract solution Middle addition KOH- ethanol solutions carry out saponification, are extracted after the completion of saponification, finally wash and are concentrated under reduced pressure;
Step 4, isolated and purified using chromatography, be control with β-kryptoxanthin standard items, collect simultaneously containing sterol and β- The eluent of kryptoxanthin;
Step 5, the eluent that will be obtained in step 4 are concentrated, and obtain concentrate;
Step 6, the concentrate of eluent first from n-hexane-acetone to being obtained in step 4 carry out Double solvent method Crystallization, crystallizes out stigmasterol crystal, then the washing lotion after above-mentioned removal stigmasterol crystal is concentrated again, obtain mainly containing β- The concentrate of kryptoxanthin, is finally crystallized from ether-methanol, is just crystallized out β-kryptoxanthin crystal.
In above-mentioned steps two, citrus peel meal is extracted under conditions of 38~45 DEG C.
In above-mentioned steps three, the mass concentration of the extract solution is 0.046~0.056%, and the KOH- ethanol is molten The mass concentration of liquid is 8~12%, and the extract solution is 1 with the volume ratio of KOH- ethanol solutions:1, saponification time is 12h。
In above-mentioned steps three, after the completion of saponification, isometric n-hexane is added to be extracted, isolated n-hexane Phase, then n-hexane phase is washed with the NaCl aqueous solution that isometric mass concentration is 0.5%, finally it is concentrated under reduced pressure.
In above-mentioned steps four, using silica gel column chromatography separating purification, using n-hexane wet method dress post, using n-hexane:Third Ketone:Methyl alcohol=92.5:7:0.5 volume ratio isocratic elution, and detected with thin-layered chromatography.
In above-mentioned steps six, after crystallizing out stigmasterol crystal, crystal is cleaned with n-hexane, until crystal is colourless;Again will be molten Liquid carries out concentrate drying, and dried material is crystallized from ether-methanol finally, obtains β-kryptoxanthin crystal, is used in combination Methyl alcohol cleans crystal, untill methyl alcohol cleaning fluid is colourless.
The condition of thin-layer chromatography is in above-mentioned steps four:Solvent is petroleum ether:Ether=7:3, developer is 10% sulphur Acid-absolute ethyl alcohol, 95 DEG C of baking 2min.
Beneficial effect:Using a kind of separated in synchronization from orange peel of the invention and the side of purifying β-kryptoxanthin and stigmasterol Method, can extract β-kryptoxanthin and stigmasterol from orange peel simultaneously, and method simple practical, good separating effect, separation product is pure Degree is high, is adapted to industrialized production.
Brief description of the drawings
Fig. 1 is the flow chart that the present invention is obtained;
Fig. 2 is the infrared spectrogram of the stigmasterol that the present invention is obtained;
Fig. 3 is the stigmasterol that the present invention is obtained1H-NMR spectrum;
Fig. 4 is the stigmasterol that the present invention is obtained13C-NMR spectrograms;
Fig. 5 is β-kryptoxanthin that the present invention is obtained1H-NMR spectrum;
Fig. 6 is the high-efficient liquid phase chromatogram of β-kryptoxanthin standard items;
Fig. 7 is the high-efficient liquid phase chromatogram of β-kryptoxanthin that the present invention is obtained;
The microphoto of β-kryptoxanthin that Fig. 8 present invention is obtained;
The microphoto of the stigmasterol that Fig. 9 present invention is obtained.
Specific embodiment
With reference to embodiment, the invention will be further described.
A kind of method of purifying β-kryptoxanthin of the separated in synchronization from orange peel and stigmasterol, comprises the following steps:
Step one, by orange peel in drying and be milled under 40 DEG C of temperature conditionss;
Step 2, in 38~45 DEG C of water-bath, extract pretreated raw material 2 times with absolute ethyl alcohol, merge and extract Liquid, is concentrated under reduced pressure to give total ester extract;
Step 3, total ester extract is dissolved in n-hexane obtains extract solution first, the extract solution Mass concentration is 0.046~0.056%, then carries out saponification to addition KOH- ethanol solutions in extract solution, the KOH- The mass concentration of ethanol solution is 8~12%, and the extract solution is 1 with the volume ratio of KOH- ethanol solutions:1, during saponification Between be 12h;After the completion of saponification, isometric n-hexane is added to be extracted, isolated n-hexane phase, then with isometric Mass concentration be 0.5% the NaCl aqueous solution washing n-hexane phase, be finally concentrated under reduced pressure.
Step 4, using silica gel column chromatography separating purification, using n-hexane wet method dress post, using n-hexane:Acetone:Methyl alcohol =92.5:7:0.5 volume ratio isocratic elution, and detected with thin-layered chromatography, it is control with β-kryptoxanthin standard items, collect master Contain the eluent of β-kryptoxanthin and stigmasterol;
The condition of the thin-layer chromatography is:Solvent is petroleum ether:Ether=7:3, developer is 10% sulfuric acid-anhydrous second Alcohol, 95 DEG C of baking 2min.
Step 5, Double solvent method crystallization is carried out to the concentrate of the eluent from n-hexane-acetone first, wherein third Ketone is the good solvent of stigmasterol, and n-hexane is the poor solvent of stigmasterol, stigmasterol crystal is crystallized out under the conditions of 25 DEG C, with just Hexane cleans crystal, until crystal is colourless;
Solution is carried out into concentrate drying again, dried material is crystallized from ether-methanol finally, wherein ether It is the good solvent of β-kryptoxanthin crystal, methyl alcohol is the poor solvent of β-kryptoxanthin, crystallization obtains β-kryptoxanthin under the conditions of 25 DEG C Crystal, and clean crystal with methyl alcohol, the purity of its β-kryptoxanthin is up to 98.48%.
The identification of crystallized product:
First, the infrared spectrum analysis of white crystals
Fig. 2 is stigmasterol crystal infrared spectrogram, and Fig. 2 is analyzed:3500-3200cm-1Place is wide and strong bands of a spectrum are The absorption band that O-H stretching vibrations cause, it is a key character bands of a spectrum of fatty alcohol.2870 and 2949 is the C-H of methyl Stretching vibration peak, 1448 and 1373 for methylene C-H deformation vibration the absworption peaks.The relatively low weak peak of intensity is C=C at 1651 The stretching vibration absworption peak of double bond, weak peak is the stretching vibration absworption peak of C-O keys, the above infrared spectrum characteristic peak at 1060 The compound is embodied for steroidal compounds.
2nd, crystallized product nuclear magnetic spectrum analysis
Above β-kryptoxanthin crystal and stigmasterol crystal are carried out into nmr analysis, as a result as shown in Fig. 3 to Fig. 5, wherein Fig. 3 It is above stigmasterol1H-NMR spectrum, Fig. 4 is above stigmasterol13C-NMR spectrograms, Fig. 5 is above β-kryptoxanthin1H- NMR spectra.
Fig. 3 is analyzed:1H-NMR(400MHz,CDCl3) 6 methyl signals peaks are had in spectrum, it is respectively 0.69 (d, J =7.3Hz, 3H);0.74–0.93(m,9H);0.93-1.01(m,6H).In 5.02 (dd, J=15.2,8.6Hz, 1H) and 5.15 (dd, J=15.2,8.6Hz, 1H) is the trans alkene hydrogen signal in 22 and 23 double bonds;5.35 (dt, J=4.8,1.9Hz, 1H) are The olefinic carbon hydrogen signal of C-6;One company's oxygen carbon signal 3.51 (m, 1H);
Fig. 4 is analyzed:13C-NMR (125MHz, CDCl3) spectrum provide 29 carbon signals altogether.δ140.79、δ138.32、 δ 129.33, four olefinic carbon signals of δ 121.72 (C-5, C-22, C-23, C-6), wherein δ 140.79 (C-5) are quaternary carbon signal;In δ 42.34 (C-13), δ 36.54 (C-10) place are 2 signal peaks of quaternary carbon;Signal peak at δ 71.82 (C-3) place is one and oxygen Connected carbon signal, remaining carbon signal is the carbon signal of alkyl, and the content according to described in existing document is inferred, the sterol material It is probably stigmasterol.
Fig. 5 is analyzed:1H-NMR(400MHz,CDCl3) 10 methyl signals peaks are had in spectrum, respectively:1.03 (s, Me-16 ', Me-17 '), 1.07 (s, Me-16, Me-17), 1.72 (s, Me-18 '), 1.74 (s, Me-18), 1.97 (s, Me- 19,Me-20,Me-19′,Me-20′).Additionally, 4.02 (m, 1H) are O-H alcoholic extract hydroxyl group signal peaks;1.0-2.0 is alkane=CH- knots Structure signal peak;2.0-3.0 is alkene-CH=CH2 signal peaks;6.0-7.0 is aromatic hydrocarbons CH2-C=signal peaks.The result and document Described content is basically identical.
The analysis of Fig. 2, Fig. 3, Fig. 4 and Fig. 5 is understood, the product that can be obtained with the preliminary judgement present invention as β-kryptoxanthin and Stigmasterol.
3rd, crystallized product thin-layer chromatographic analysis
Above β-kryptoxanthin crystal and stigmasterol crystal are carried out into thin-layer chromatographic analysis, and using β-kryptoxanthin standard items and Stigmasterol standard items are contrasted.Thin-layer chromatography condition:Solvent is petroleum ether:Ether=7:3, developer is 10% sulfuric acid-anhydrous Ethanol, 95 DEG C of baking 2min.Determine the R of each groupfValue, the results are shown in Table 1:
The R of table 1, crystallized product and standard itemsfValue
As can be seen from Table 1, the R of above crystal and corresponding standard itemsfValue is equal, in the base of above nuclear magnetic spectrum analysis On plinth, it is possible to determine that the product that the present invention is obtained is very likely β-kryptoxanthin and stigmasterol.And after colour developing is heated, β-hidden Huang Element is in aubergine in dark blue-green, stigmasterol, consistent with associated description.
4th, efficient liquid phase chromatographic analysis
Efficient liquid phase chromatographic analysis are carried out to β-kryptoxanthin standard items and β-kryptoxanthin crystallization;High-efficient liquid phase chromatogram condition For:Mobile phase A is ethyl acetate, and Mobile phase B is 90% acetonitrile, A:B=40:60, isocratic elution;Flow velocity is 1mL/min;Post Temperature is 30 DEG C.Fig. 6 and Fig. 7 are respectively the high-efficient liquid phase chromatogram of β-kryptoxanthin standard items and β-kryptoxanthin crystallization.The He of comparison diagram 6 Fig. 7 understands that the appearance time of the β that the present invention is obtained-kryptoxanthin crystallization is 14.073min, during with β-kryptoxanthin standard items appearance Between 14.050min be consistent, i.e., differentiate from high performance liquid chromatography and understand, the β-kryptoxanthin crystallization as β that the present invention is obtained-hidden Flavine.
5th, crystalline mi morphological analysis
Fig. 8 and Fig. 9 are respectively the microphoto of product β-kryptoxanthin of the present invention and stigmasterol, it can be seen from figure 7 that β- Kryptoxanthin in the form of sheets, with metallic luster;Stigmasterol is mainly acicular crystal, and this result is consistent with document report.
In sum, using the method for the present invention, β-kryptoxanthin and stigmasterol can be separated and purify from orange peel simultaneously.
Finally it should be noted that foregoing description is only the preferred embodiments of the present invention, the ordinary skill people of this area Member on the premise of without prejudice to present inventive concept and claim, can make table as multiple types under enlightenment of the invention Show, such conversion is each fallen within protection scope of the present invention.

Claims (7)

1. a kind of separated in synchronization from orange peel and purifying β-kryptoxanthin and stigmasterol method, it is characterised in that including following step Suddenly:
Step one, orange peel is dried and is milled;
Step 2, pretreated raw material is extracted with absolute ethyl alcohol, be concentrated under reduced pressure to give total ester extract;
Step 3, the step 2 total ester extract of gained is dissolved in extract solution is obtained in n-hexane first, then it is molten to extract KOH- ethanol solutions are added in liquid carries out saponification, is extracted after the completion of saponification, finally washes and is concentrated under reduced pressure;
Step 4, isolated and purified using chromatography, be control with β-kryptoxanthin standard items, collected and contain sterol and β-hidden Huang simultaneously The eluent of element;
Step 5, the eluent that will be obtained in step 4 are concentrated, and obtain concentrate;
Step 6, first from n-hexane-acetone to step 5 gained eluent concentrate carry out Double solvent method crystallization, crystallize Go out stigmasterol crystal, then the washing lotion after above-mentioned removal stigmasterol crystal is concentrated, obtain the mainly concentration containing β-kryptoxanthin Thing, is finally crystallized from ether-methanol, crystallizes out β-kryptoxanthin crystal.
2. the method that a kind of separated in synchronization from orange peel according to claim 1 purifies β-kryptoxanthin and stigmasterol, its It is characterised by:In the step 2, citrus peel meal is extracted under conditions of 38~45 DEG C.
3. the method that a kind of separated in synchronization from orange peel according to claim 1 and 2 purifies β-kryptoxanthin and stigmasterol, It is characterized in that:In the step 3, the mass concentration of the extract solution is 0.046~0.056%, the KOH- ethanol The mass concentration of solution is 8~12%, and the extract solution is 1 with the volume ratio of KOH- ethanol solutions:1, saponification time is 12h。
4. the method that a kind of separated in synchronization from orange peel according to claim 3 purifies β-kryptoxanthin and stigmasterol, its It is characterised by:In the step 3, after the completion of saponification, add isometric n-hexane to be extracted, it is isolated just oneself Alkane phase, then n-hexane phase is washed with the NaCl aqueous solution that isometric mass concentration is 0.5%, finally it is concentrated under reduced pressure.
5. the method that a kind of separated in synchronization from orange peel according to claim 1 purifies β-kryptoxanthin and stigmasterol, its It is characterised by:In the step 4, using silica gel column chromatography separating purification, using n-hexane wet method dress post, using n-hexane:Third Ketone:Methyl alcohol=92.5:7:0.5 volume ratio isocratic elution, and detected with thin-layered chromatography.
6. a kind of separated in synchronization from orange peel purifying β-kryptoxanthin according to claim 1 or 2 or 5 and the side of stigmasterol Method, it is characterised in that:In the step 6, after crystallizing out stigmasterol crystal, crystal is cleaned with n-hexane, until crystal is colourless; Washing lotion is carried out into concentrate drying again, dried material is crystallized from ether-methanol finally, obtain β-kryptoxanthin brilliant Body, and crystal is cleaned with methyl alcohol, untill colourless for the methyl alcohol for cleaning.
7. the method that a kind of separated in synchronization from orange peel according to claim 5 purifies β-kryptoxanthin and stigmasterol, its The condition for being characterised by thin-layer chromatography in step 4 is:Solvent is petroleum ether:Ether=7:3, developer is 10% sulfuric acid-nothing Water-ethanol, 95 DEG C of baking 2min.
CN201510941144.1A 2015-12-16 2015-12-16 A kind of method of the separated in synchronization from orange peel and purifying β kryptoxanthin and stigmasterol Expired - Fee Related CN105541687B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510941144.1A CN105541687B (en) 2015-12-16 2015-12-16 A kind of method of the separated in synchronization from orange peel and purifying β kryptoxanthin and stigmasterol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510941144.1A CN105541687B (en) 2015-12-16 2015-12-16 A kind of method of the separated in synchronization from orange peel and purifying β kryptoxanthin and stigmasterol

Publications (2)

Publication Number Publication Date
CN105541687A CN105541687A (en) 2016-05-04
CN105541687B true CN105541687B (en) 2017-05-31

Family

ID=55821304

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510941144.1A Expired - Fee Related CN105541687B (en) 2015-12-16 2015-12-16 A kind of method of the separated in synchronization from orange peel and purifying β kryptoxanthin and stigmasterol

Country Status (1)

Country Link
CN (1) CN105541687B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106380501B (en) * 2016-08-09 2018-04-24 右江民族医学院 A kind of method that stigmasterol is extracted in the stem from Job's tears
CN109717485A (en) * 2019-02-15 2019-05-07 湖北土老憨调味食品股份有限公司 It is a kind of from tangerine orange produce tangerine vinegar after tangerine slag in continuously acquire the preparation method of orange pigment and dietary fiber
CN110208443A (en) * 2019-06-21 2019-09-06 广东食品药品职业学院 A kind of method of carotenoid in extraction Mango Fruit

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101863955A (en) * 2010-05-10 2010-10-20 孙志高 Process for hierarchically extracting limonin, flavonoid and dietary fiber from orange peel residues
CN102057048A (en) * 2008-04-09 2011-05-11 索拉兹米公司 Direct chemical modification of microbial biomass and microbial oils

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102057048A (en) * 2008-04-09 2011-05-11 索拉兹米公司 Direct chemical modification of microbial biomass and microbial oils
CN101863955A (en) * 2010-05-10 2010-10-20 孙志高 Process for hierarchically extracting limonin, flavonoid and dietary fiber from orange peel residues

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
柑橘皮里功能性物质种类及其提取工艺的研究进展;苏东林等;《现代食品科技》;20070315(第03期);第90-94页 *
温州蜜柑皮β-隐黄素的分离和纯化;孙志高 等;《食品科学》;20131231;第34卷(第12期);第11-15页 *
溶剂和超声波辅助提取温州蜜柑皮β-隐黄素的条件优化;蒋国玲 等;《食品添加剂》;20120701(第13期);第294-298页 *

Also Published As

Publication number Publication date
CN105541687A (en) 2016-05-04

Similar Documents

Publication Publication Date Title
MS et al. Techniques for the extraction of phytosterols and their benefits in human health: A review
Pierre et al. Isolation and characterisation of stigmasterol and β-sitosterol from Odontonema strictum (acanthaceae)
Chen et al. A new phragmalin-type limonoid and anti-inflammatory constituents from the fruits of Swietenia macrophylla
CN101899070B (en) Preparation method for fast separating flavonoid glycosides from oil-tea-cakes with medium pressure column
Deore et al. Isolation and characterization of phytoconstituents from Chlorophytum borivilianum
CN105017182B (en) A kind of method that taxol is extracted from Chinese yew
CN105541687B (en) A kind of method of the separated in synchronization from orange peel and purifying β kryptoxanthin and stigmasterol
CN101139373A (en) Method for rapid scale extraction and purification of flax lignan
Maurya et al. Amritosides A, B, C and D: Clerodane furano diterpene glucosides from Tinospora cordifolia
Dikshit et al. Advances in various techniques for isolation and purification of sterols
CN101870637A (en) Technology for extracting and preparing policosanol
CN103304617B (en) A kind of phenols plant sterol functional molecular and preparation method thereof
CN110615824B (en) Method for separating triterpene alcohol and sterol from crude sterol of rice bran
Tin et al. Isolation and structure elucidation of triterpenes from inflorescence of banana (Musa balbisiana cv. Saba).
CN103467556B (en) A kind of preparation method of phytosterol cinnamate
CN102977066A (en) Method for extracting and purifying isoflavones in soybean
CN109678675A (en) A method of separation cannabidiol
Singh et al. A new pentacyclic triterpene acid from Lantana indica
CN103113439A (en) Method for preparing kaempferol-3-O-Beta-D-glucuronide in euphorbia sororia
Dhalani et al. Evaluation of non-polar composition in Plumbago zeylanica leaves by gas chromatography and mass spectrometry
Satiraphan et al. A new 3, 4-seco-cycloartane from the leaves of Hopea odorata Roxb.
Báthori et al. New minor ecdysteroids from Silene otites (L.) Wib.
CN107353296B (en) A method of extracting activated protein and eurycomanone from Tongkat Ali
CN109912666A (en) A method of extracting high-purity aurantiin and neohesperidin simultaneously from Fructus Aurantii
Lee et al. Anti-inflammatory and cytotoxic compounds from solanum macaonense

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20170531

Termination date: 20191216

CF01 Termination of patent right due to non-payment of annual fee